These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 39294640)

  • 1. Altered metabolism in cancer: insights into energy pathways and therapeutic targets.
    Tufail M; Jiang CH; Li N
    Mol Cancer; 2024 Sep; 23(1):203. PubMed ID: 39294640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
    Allison KE; Coomber BL; Bridle BW
    Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy.
    Masci D; Puxeddu M; Silvestri R; La Regina G
    Molecules; 2024 May; 29(9):. PubMed ID: 38731601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
    Zhang Y; Yang JM
    Cancer Biol Ther; 2013 Feb; 14(2):81-9. PubMed ID: 23192270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role and targetability of the TCA cycle in cancer metabolism.
    Anderson NM; Mucka P; Kern JG; Feng H
    Protein Cell; 2018 Feb; 9(2):216-237. PubMed ID: 28748451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation.
    Schiliro C; Firestein BL
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.
    Chen JQ; Russo J
    Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
    Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
    Front Immunol; 2019; 10():1399. PubMed ID: 31275326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
    Marchiq I; Pouysségur J
    J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.
    Frattaruolo L; Brindisi M; Curcio R; Marra F; Dolce V; Cappello AR
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
    Mathupala SP
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OXPHOS inhibitors, metabolism and targeted therapies in cancer.
    Cadassou O; Jordheim LP
    Biochem Pharmacol; 2023 May; 211():115531. PubMed ID: 37019188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development of cancer therapeutics that target metabolism.
    Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
    QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.